Vanda Pharmaceuticals

$16.45
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.14 (+0.86%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell VNDA and other stocks, options, and ETFs commission-free!

About VNDA

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder.

CEO

Mihael Hristos Polymeropoulos

Employees

292

Headquarters

Washington, District of Columbia

Founded

2002

Market Cap

941.95M

Price-Earnings Ratio

37.65

Dividend Yield

—

Average Volume

501.85K

High Today

$16.74

Low Today

$16.42

Open Price

$16.42

Volume

266.36K

52 Week High

$20.51

52 Week Low

$9.00

VNDA Earnings

$0.00

$0.08

$0.15

$0.23

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 5, After Hours